(VIANEWS) – Trinity Industries (TRN), Bogota Financial Corp. (BSBK), Pfizer (PFE) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Trinity Industries (TRN)

56.6% sales growth and 4.68% return on equity

Trinity Industries, Inc. provides rail transportation products and services under the TrinityRail name in North America. It operates in two segments, Railcar Leasing and Management Services Group, and Rail Products Group. The Railcar Leasing and Management Services Group segment leases freight and tank railcars; originates and manages railcar leases for third-party investors; and provides fleet maintenance and management services. As of December 31, 2021, it had a fleet of 106,970 owned or leased railcars. This segment serves industrial shipper and railroad companies operating in agriculture, construction and metals, consumer products, energy, and refined products and chemicals markets. The Rail Products Group segment manufactures freight and tank railcars for transporting various liquids, gases, and dry cargo; and offers railcar maintenance and modification services. This segment serves railroads, leasing companies, and industrial shippers of products in the agriculture, construction and metals, consumer products, energy, and refined products and chemicals markets. It sells or leases products and services through its own sales personnel and independent sales representatives. Trinity Industries, Inc. was incorporated in 1933 and is headquartered in Dallas, Texas.

Earnings per Share

Trinity Industries’ trailing twelve-month EPS is $-2.67.

For the 12 trailing months, the company’s return-on-equity, which is an indicator of the business’ profitability relative to shareholders’ equity, was 4.68%.

Volume

Trinity Industries’ last reported volume is now 233571, which is 61.97% less than its average volume 614257.

Annual Top and Bottom Value

Trinity Industries stock was valued at $30.49 as of 10:22 EST. This is way lower than the 52-week high at $35.35, and much higher than the 52-week low at $20.94.

2. Bogota Financial Corp. (BSBK)

34.1% sales growth and 4.29% return on equity

Bogota Financial Corp. operates as the bank holding company for Bogota Savings Bank that provides banking products and services in the United States. It offers deposit accounts, including demand accounts, savings accounts, money market accounts, and certificate of deposit accounts. The company also provides one- to four-family residential real estate loans, and commercial real estate and multi-family loans, as well as consumer loans, commercial and industrial loans, and construction loans; and buys, sells, and holds investment securities. As of January 15, 2020, it operated two offices located in Bogota and Teaneck, New Jersey. The company was founded in 1893 and is based in Teaneck, New Jersey.

Earnings Per Share

As for profitability, Bogota Financial Corp. has a trailing twelve months EPS of $0.49.

PE Ratio

Bogota Financial Corp. has a trailing twelve months price to earnings ratio of 23.46. Meaning,
the purchaser of the share is investing $23.46 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.29%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 114.3% and 14.3%, respectively.

Volume

Today’s last reported volume for Bogota Financial Corp. is 91172 which is 918.45% above its average volume of 8952.

3. Pfizer (PFE)

14.6% sales growth and 37.4% return on equity

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Earnings per Share

Pfizer’s trailing 12 month EPS is $1.71.

PE Ratio

Pfizer’s trailing 12-month price-earnings ratio is 29.63. The purchaser of the shares is therefore investing $29.63 per dollar in annual earnings.

For the 12 trailing months, the company’s return-on-equity, which is a measure of the business’ profitability relative to shareholders’ equity, was 37.4%.

Previous days news about Pfizer(PFE)

  • According to FXStreet on Tuesday, 6 December, "BioNTech SE (BNTX),Moderna Inc (MRNA)&Pfizer Inc (PFE): Pfizer and its German partner, BioNTech fired back at Moderna on Monday in a patent lawsuit over their rival COVID-19 vaccines, seeking dismissal of the lawsuit in Boston federal court and an order that Moderna’s patents are invalid and not infringed."

4. Benchmark Electronics (BHE)

11.8% sales growth and 6.05% return on equity

Benchmark Electronics, Inc., along with its affiliates, offers product design, engineering solutions, technology solutions, advanced manufacturing services, and other services throughout the Americas, Asia, Europe, and Africa. It offers technology services, such as new product design, prototyping, testing and other engineering services. Custom testing and equipment design and building services are also offered. The company also offers testing and manufacturing services in electronics, including printed circuit board assembly, test solutions, component reliability testing and component testing. It also provides component engineering services. The company also offers electromechanical assembly and precision machining services. It also provides subsystem integration and service, which includes configuration and testing for different industries. It also offers value-added services such as supply chain management and direct order fulfillment. Aftermarket non-warranty service includes repair, replacement and refurbishment of products, exchanges, upgrades, spare parts manufacturing, and repairs. It serves OEMs in aerospace, defense, medical technology, test and measurement, telecommunications and high-end computing. The company sells its products mostly through direct sales. Electronics, Inc. was the company’s former name. Benchmark Electronics, Inc., was established in 1979. It is located in Tempe, Arizona.

Earnings Per Share

As for profitability, Benchmark Electronics has a trailing twelve months EPS of $1.67.

PE Ratio

Benchmark Electronics has a trailing twelve months price to earnings ratio of 16.85. Meaning,
the purchaser of the share is investing $16.85 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.05%.

Volume

Today’s last reported volume for Benchmark Electronics is 58111 which is 61.67% below its average volume of 151609.

5. Vornado Realty Trust (VNO)

7.7% sales growth and 3.12% return on equity

Vornado has a strong portfolio in New York City, the country’s most important market. Vornado also leads the industry in sustainable policy. Vornado has over 23,000,000 square feet of LEED-certified buildings under its management. The company was awarded the Energy Star Partner of the year Award for Sustained Excellence 2019 and the Energy Star Partner of the Years Award. Vornado celebrated 50 years of service to the NYSE in 2012.

Earnings Per Share

As for profitability, Vornado Realty Trust has a trailing twelve months EPS of $-1.84.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.12%.

Yearly Top and Bottom Value

Vornado Realty Trust’s stock is valued at $24.66 at 10:22 EST, way below its 52-week high of $47.26 and way higher than its 52-week low of $20.03.

Moving Average

Vornado Realty Trust’s worth is above its 50-day moving average of $23.53 and way under its 200-day moving average of $32.38.

Growth Estimates Quarters

For the current quarter, the company expects a decline of 50% in growth and a rise of 33.3% the following.

Sales Growth

Vornado Realty Trust has experienced a 10.4% and 7.7% sales growth in the current quarter.

6. Manhattan Associates (MANH)

6.8% sales growth and 51.14% return on equity

Manhattan Associates, Inc. develops, sells, deploys, services, and maintains software solutions to manage supply chains, inventory, and omni-channel operations for retailers, wholesalers, manufacturers, logistics providers, and other organizations. The company offers Manhattan SCALE, a portfolio of logistics execution solutions that provide trading partner management, yard management, optimization, warehouse management, and transportation execution services; and Manhattan Active, a set of enterprise and store omni-channel solutions. It also provides inventory optimization and planning solutions; maintenance services comprising customer support services and software enhancements; professional services, such as solutions planning and implementation, and related consulting services; and training and change management services. In addition, the company resells computer hardware, radio frequency terminal networks, radio frequency identification chip readers, bar code printers and scanners, and other peripherals. It offers products through direct sales personnel, as well as through partnership agreements with various organizations. The company operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Manhattan Associates, Inc. was founded in 1990 and is headquartered in Atlanta, Georgia.

Earnings per Share

Manhattan Associates’ trailing 12 months profit per share was $1.75

PE Ratio

Manhattan Associates’ trailing 12-month price-to-earnings ratio is 70.73. The purchaser of the shares is therefore investing $70.73 per dollar in annual earnings.

For the 12 trailing months, the company’s return-on-equity, which is a measure of the business’ profitability relative to shareholders’ equity, was 51.14%.

Sales Growth

Manhattan Associates has experienced 6.6% and 6.8% sales growth in the current quarter.

Earnings before Interest, Taxes and Depreciation

Manhattan Associates’ EBITDA stands at 10.19

Moving Average

Manhattan Associates’s value has fallen below $126.19 over its 50-day average and is lower than $129.51 for its 200-day average.